<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0340">
 <label>68</label>
 <element-citation publication-type="journal" id="rf0335">
  <person-group person-group-type="author">
   <name>
    <surname>Smolen</surname>
    <given-names>J.S.</given-names>
   </name>
   <name>
    <surname>Genovese</surname>
    <given-names>M.C.</given-names>
   </name>
   <name>
    <surname>Takeuchi</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Hyslop</surname>
    <given-names>D.L.</given-names>
   </name>
   <name>
    <surname>Macias</surname>
    <given-names>W.L.</given-names>
   </name>
   <name>
    <surname>Rooney</surname>
    <given-names>T.</given-names>
   </name>
  </person-group>
  <article-title>Safety profile of Baricitinib in patients with active rheumatoid arthritis with over 2 years median time in treatment</article-title>
  <source>J Rheumatol</source>
  <volume>46</volume>
  <year>2018</year>
  <fpage>7</fpage>
  <lpage>18</lpage>
  <pub-id pub-id-type="doi">10.3899/jrheum.171361</pub-id>
  <pub-id pub-id-type="pmid">30219772</pub-id>
 </element-citation>
</ref>
